Related Experiment Video

Updated: Jun 30, 2025

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

12.7K

Biochemical pharmacology of adenylyl cyclases in cancer

Bikash Chandra Jena1, Daniel P Flaherty1, Valerie P O'Brien1

  • 1Borch Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, USA.

Biochemical Pharmacology
|March 24, 2024
PubMed

Insights

Adenylyl cyclases (ACs) play a role in cancer progression and suppression. Targeting AC overactivation offers potential for new anticancer therapies and personalized oncology treatments.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cancer remains a leading cause of mortality worldwide.
  • Understanding cancer signaling pathways is crucial for developing new therapeutic targets.
  • The adenylyl cyclase (AC) superfamily regulates intracellular signaling via cyclic AMP (cAMP).

Purpose of the Study:

  • To review the involvement of mammalian adenylyl cyclase (AC) isoforms in cancer progression and suppression.
  • To explore the mechanisms of ACs in cancer cell proliferation and invasion.
  • To discuss potential anticancer strategies targeting AC signaling.

Main Methods:

  • Literature review of existing research on adenylyl cyclases (ACs) and cancer.
  • Analysis of AC expression patterns in various cancer types.
  • Discussion of small molecules and inhibitors targeting AC activity.

Main Results:

  • ACs are implicated in both promoting and suppressing cancer progression.
  • AC overactivation is a potential target for novel anticancer therapies.
  • Expression patterns of ACs vary significantly across different cancers.

Conclusions:

  • Further understanding of AC signaling components can lead to novel therapeutic strategies.
  • Targeting ACs may enhance the efficacy of chemoimmunotherapy for various cancers.
  • AC modulation presents opportunities for personalized oncology treatments.
Keywords:
Adenylyl CyclaseCancerG proteinGPCRHallmarks of CancercAMP signaling

More Related Videos

Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor06:03

Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor

Published on: March 22, 2024

902
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.9K

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
46.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K